Evaluation of a multimedia marketing campaign to engage African American patients in glaucoma screening.

African Americans Blindness Glaucoma Marketing campaign Minority populations Ophthalmology Screenings

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 03 09 2019
revised: 23 12 2019
accepted: 21 01 2020
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 7 2 2020
Statut: epublish

Résumé

Our objective was to determine which messaging approaches from a marketing campaign were most effective in recruiting African American individuals to a glaucoma screening and research study. We conducted a multimedia marketing campaign in Philadelphia from 01/31/2018 to 06/30/2018. Messaging approaches included radio advertisements and interviews (conducted in partnership with a local radio station with a large African American listener base), print materials, event tables, and online postings. Participants received free glaucoma screenings and the opportunity to enroll in our glaucoma genetics study. These screenings allowed individuals with glaucoma to receive a full examination and treatment plan with a glaucoma specialist, as well as to contribute to future efforts to identify genetic variants underlying this disease. We compared inquiry, enrollment, and cost yield for each messaging approach. Our campaign resulted in 154 unique inquiries, with 98 patients receiving glaucoma screenings (64%) and 60 patients enrolling in our study (39%). Commercials on WURD radio yielded the highest number of inquiries (62%) and enrollments (62%), but at relatively high cost ($814/enrolled patient). The most inexpensive approach that yielded more than five enrollments was postcards ($429/enrolled patient). Our campaign suggests that high-frequency commercials and postcards distributed at targeted healthcare locations are particularly effective and affordable options for connecting with the African American community. Our findings can help to inform recruitment efforts for other understudied diseases in minority populations.

Identifiants

pubmed: 32025476
doi: 10.1016/j.pmedr.2020.101057
pii: S2211-3355(20)30017-6
pii: 101057
pmc: PMC6997297
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101057

Subventions

Organisme : NEI NIH HHS
ID : L30 EY029353
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY001583
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY023557
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY030163
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY029765
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 The Authors.

Références

Contemp Clin Trials. 2012 Jan;33(1):67-75
pubmed: 21983626
Hum Mol Genet. 2014 Dec 15;23(24):6634-43
pubmed: 25027321
Am J Hum Genet. 2017 Apr 6;100(4):635-649
pubmed: 28366442
J Community Genet. 2011 Dec;2(4):223-31
pubmed: 22109875
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Am J Public Health. 2017 Jan;107(1):173-179
pubmed: 27854527
Annu Rev Public Health. 2004;25:419-37
pubmed: 15015928
Cell. 2019 Mar 21;177(1):26-31
pubmed: 30901543
Ophthalmology. 2016 Jan;123(1):P41-P111
pubmed: 26581556
J Med Genet. 1999 Jan;36(1):41-4
pubmed: 9950364
Nat Rev Dis Primers. 2016 Sep 22;2:16067
pubmed: 27654570
Lancet. 2010 Aug 28;376(9742):739-41
pubmed: 20599264
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1751-1759
pubmed: 29610859
Ophthalmology. 2015 Apr;122(4):711-20
pubmed: 25576993
Am J Prev Med. 2009 Dec;37(6 Suppl 1):S195-200
pubmed: 19896019
J Gen Intern Med. 2007 Jun;22(6):852-63
pubmed: 17375358
J Am Coll Cardiol. 2006 Apr 18;47(8):1724-5
pubmed: 16631014
BMC Med Res Methodol. 2017 Jul 14;17(1):101
pubmed: 28705151
Am J Public Health. 2014 May;104(5):847-53
pubmed: 24625177
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):66-76
pubmed: 18172076
Prev Med. 1998 Nov-Dec;27(6):838-45
pubmed: 9922066
Arch Ophthalmol. 2000 Jun;118(6):819-25
pubmed: 10865321
Clin Pharmacol Ther. 2017 Sep;102(3):397-404
pubmed: 28198005
Am J Ophthalmol. 2018 Aug;192:239-247
pubmed: 29555482
Nature. 2016 Oct 12;538(7624):161-164
pubmed: 27734877
Prog Retin Eye Res. 2017 May;58:89-114
pubmed: 28223208
Invest Ophthalmol Vis Sci. 2013 Sep 17;54(9):6248-54
pubmed: 23963167
Gerontologist. 2011 Jun;51 Suppl 1:S134-41
pubmed: 21173436

Auteurs

Ava Kikut (A)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Marquis Vaughn (M)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Rebecca Salowe (R)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Mohima Sanyal (M)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Sayaka Merriam (S)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Roy Lee (R)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Emily Becker (E)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Sara Lomax-Reese (S)

WURD Radio, Philadelphia, PA, USA.

Monica Lewis (M)

WURD Radio, Philadelphia, PA, USA.

Robert Ryan (R)

TrialX, New York, NY, USA.

Ahmara Ross (A)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Qi N Cui (QN)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Victoria Addis (V)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Prithvi S Sankar (PS)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Eydie Miller-Ellis (E)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Carolyn Cannuscio (C)

Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Joan O'Brien (J)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Classifications MeSH